January 10, 2017 / 10:31 PM / 7 months ago

BRIEF-Valeant Pharma reiterates its FY 2016 forecast

Jan 10 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant Pharmaceuticals International Inc - Reiterating its full-year 2016 financial guidance, which was originally communicated in november 2016

* FY 2016 earnings per share view $5.43, revenue view $9.60 billion -- Thomson Reuters I/B/E/S Source: (bit.ly/2j2Tiup) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below